Name | Value |
---|---|
Revenues | 244.0M |
Cost of Revenue | 0.0M |
Gross Profit | 244.0M |
Operating Expense | 5.8M |
Operating I/L | -5.8M |
Other Income/Expense | -0.7M |
Interest Income | 0.0M |
Pretax | -6.5M |
Income Tax Expense | -60.2M |
Net Income/Loss | -6.5M |
Conduit Pharmaceuticals Limited is a clinical stage specialty biopharmaceutical company focused on addressing unmet medical needs in autoimmune disease and idiopathic male infertility. The company generates revenue through the development and potential commercialization of innovative pharmaceutical products targeting these specific medical conditions.